AI Drives Interoperability in One Health Systems for AMR

Artificial intelligence (AI) is emerging as a pivotal force in enhancing interoperability within One Health systems aimed at combating antimicrobial resistance (AMR). The World Health Organization has classified AMR as a 'silent pandemic,' responsible for approximately 1.27 million deaths each year, with projections suggesting that this figure could rise to 10 million by 2050 if effective interventions are not implemented. The urgency of addressing AMR is underscored by the economic burden it imposes, particularly on low- and middle-income countries, where health systems are often least equipped to handle such crises.

The One Health approach recognizes the interconnectedness of human, animal, and environmental health, advocating for coordinated responses to AMR. Despite the endorsement of this framework by major global health organizations, significant gaps remain in the implementation of integrated surveillance systems. Current data infrastructures are fragmented, characterized by isolated data silos and a lack of interoperability, which hampers effective monitoring and response efforts. The result is a landscape where vital information is not shared across sectors, limiting the ability to track resistance patterns and develop comprehensive interventions.

AI presents a transformative opportunity to address these interoperability challenges. By employing techniques such as federated learning, AI can facilitate collaborative data analysis without compromising privacy or requiring the movement of sensitive information. This approach allows for the training of AI models across diverse datasets while maintaining data sovereignty, which is particularly crucial for countries with underdeveloped data protection frameworks. Additionally, natural language processing (NLP) can harmonize disparate data formats, enabling a more cohesive understanding of AMR across various health domains.

The implications of improved interoperability are significant. Enhanced data sharing and analysis can lead to more effective surveillance of AMR, enabling health authorities to identify transmission pathways and evaluate the effectiveness of interventions across human, animal, and environmental health sectors. This holistic approach is essential for mitigating the impact of AMR, which does not recognize sectoral boundaries and requires a unified response.

Looking ahead, the integration of AI into One Health systems for AMR surveillance is not merely a technological advancement but a necessary evolution in public health strategy. As stakeholders continue to explore innovative solutions, the focus must remain on fostering collaboration across sectors and ensuring that AI technologies are deployed in ways that enhance data sharing and improve health outcomes globally.